Drug profile

The FDA adverse-event record for Multivitamin Supplement

109 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Multivitamin Supplement. See the species affected, top reactions, and outcomes below.

109
adverse-event reports
2.8%
death-coded share
Dog
most-reported species
24
Vomiting - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
109
Total Reports
3
Deaths Reported
2.8%
Death Rate

Active Ingredients

Multivitamin Supplement

Administration Routes

OralUnknownParenteralCutaneous

Species Affected

Dog 83
Human 22
Cattle 2
Cat 2

Most Affected Breeds

Unknown 22
Retriever - Labrador 13
Crossbred Canine/dog 4
Shepherd Dog - German 4
Pit Bull 4
Chihuahua 4
Terrier - Yorkshire 3
Terrier - Jack Russell 3
Retriever - Golden 3
Collie (unspecified) 3

Most Reported Reactions

Vomiting 24
Lethargy (see also Central nervous system depression in 'Neurological') 24
Accidental exposure 15
Diarrhoea 13
Emesis 9
Ataxia 7
Lack of efficacy - NOS 7
Not eating 7
Other abnormal test result NOS 7
Headache 7
Walking difficulty 4
Behavioural disorder NOS 3

Outcome Breakdown

Recovered/Normal
48 (44.0%)
Outcome Unknown
35 (32.1%)
Ongoing
20 (18.3%)
Recovered with Sequela
3 (2.8%)
Died
2 (1.8%)
Euthanized
1 (0.9%)

Multivitamin Supplement Adverse Event Insights

109 reports name Multivitamin Supplement; 3 recorded a death outcome (2.8% of reported events, not a population-level mortality rate). Active ingredient: Multivitamin Supplement. Administration routes: Oral, Unknown, Parenteral, Cutaneous.

By species: Dog (83 reports), Human (22 reports), Cattle (2 reports). By breed: Unknown (22), Retriever - Labrador (13), Crossbred Canine/dog (4).

Leading clinical signs: Vomiting (24), Lethargy (see also Central nervous system depression in 'Neurological') (24), Accidental exposure (15), Diarrhoea (13). Outcome, 109 coded reports: Recovered/Normal leads at 44.0%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.